Gecko Health Innovations Inc. (Acq. by Teva Pharmaceuticals)

📍 Cambridge, United States🗓 Founded 2012👥 2 employees
Gecko acquired by Teva Pharmaceuticals (NYSE:TEVA) in September 2015. (PR: http://www.businesswire.com/news/home/20150925005332/en/ ) Asthma is the most common chronic childhood disease and the largest cause of hospitalization; over 500,000 admissions per year. Asthma can be effectively managed through symptom awareness and adherence to medication. Our vision is to shift families from panic to self-management by providing tools that increase awareness and adherence to improve disease management. CareTRx by Gecko is a simple device that is added to existing inhalers. It empowers children and their parents to better manage their asthma by monitoring medication use, providing reminders and increasing disease awareness. Gecko is going to revolutionize the way we think about controlling Asthma.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2012
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Gecko Health Innovations Inc. (Acq. by Teva Pharmaceuticals) founded?
Gecko Health Innovations Inc. (Acq. by Teva Pharmaceuticals) was founded in 2012.
What industry is Gecko Health Innovations Inc. (Acq. by Teva Pharmaceuticals) in?
Gecko Health Innovations Inc. (Acq. by Teva Pharmaceuticals) operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Gecko Health Innovations Inc. (Acq. by Teva Pharmaceuticals) based?
Gecko Health Innovations Inc. (Acq. by Teva Pharmaceuticals) is headquartered in Cambridge, United States.